Alliancebernstein L.P. Codexis, Inc. Transaction History
Alliancebernstein L.P.
- $290 Billion
 - Q2 2025
 
A detailed history of Alliancebernstein L.P. transactions in Codexis, Inc. stock. As of the latest transaction made, Alliancebernstein L.P. holds 118,130 shares of CDXS stock, worth $266,973. This represents 0.0% of its overall portfolio holdings.
Number of Shares
118,130
              Previous 117,815
              
        
           0.27%
        
      
          
        Holding current value
$266,973
            Previous $316,000
            
        
           8.86%
        
      
          
        % of portfolio
0.0%
            Previous 0.0%
          
        Shares
	  21 transactions
	
  Others Institutions Holding CDXS
# of Institutions
129Shares Held
66.7MCall Options Held
25.8KPut Options Held
20K- 
    
      Opaleye Management Inc. Boston, MA12.6MShares$28.5 Million7.35% of portfolio
 - 
    
      Casdin Capital, LLC New York, NY7.2MShares$16.3 Million2.46% of portfolio
 - 
    
      Black Rock Inc. New York, NY6.79MShares$15.3 Million0.0% of portfolio
 - 
    
      Vanguard Group Inc Valley Forge, PA4.59MShares$10.4 Million0.0% of portfolio
 - 
    
      Abrdn PLC4.2MShares$9.49 Million0.02% of portfolio
 
About CODEXIS, INC.
- Ticker CDXS
 - Exchange NASDAQ
 - Sector Healthcare
 - Industry Biotechnology
 - Shares Outstandng 65,494,100
 - Market Cap $148M
 - Description
 - Codexis, Inc. discovers, develops, and sells enzymes and other proteins. It offers biocatalyst products and services; intermediate chemicals products that are used for further chemical processing; and Codex biocatalyst panels and kits that enable customers to perform chemistry screening. The company also provides biocatalyst screening and protei...